Cointime

Saegis Pharmaceuticals

company

About

Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders.

  • 1 - 10

Highlights

Total Funding Amount
$30M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$30M
Industries
Biopharma,Biotechnology,Health Care,Medical
Founded date
Jan 1, 1999
Number Of Employee
1 - 10
Operating Status
Active

Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders. The company has a pipeline of treatments for central nervous system diseases involving cognitive dysfunction, including Alzheimer’s disease, mild cognitive impairment, attention deficit hyperactivity disorder, and cognitive impairment associated with schizophrenia. It develops CNS therapeutics for patients facing memory loss and cognition deficits associated with aging, psychiatric disorders, and brain trauma.

Saegis Pharmaceuticals was founded in 1999 and is based in Half Moon Bay, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Saegis Pharmaceuticals has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Nov 17, 2003 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 17, 2003 Series B $30M 1 Versant Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Saegis Pharmaceuticals is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series B
Cointime
Содержание
компания